<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font25 { font-size : 25; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">HSV </span>
   <span class="font25">patients </span>
   <span class="font21">valacyclovir </span>
   <span class="font20">treatment </span>
   <span class="font19">study </span>
   <span class="font18">antiviral </span>
   <span class="font18">simplex </span>
   <span class="font17">herpes </span>
   <span class="font17">cognitive </span>
   <span class="font16">PET </span>
   <span class="font16">amyloid </span>
   <span class="font16">brain </span>
   <span class="font16">virus </span>
   <span class="font16">{border-style </span>
   <span class="font16">Alzheimer's </span>
   <span class="font16">effect </span>
   <span class="font16">px;} </span>
   <span class="font16">trial </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">Alzheimerâ€™s </span>
   <span class="font15">University </span>
   <span class="font15">weeks </span>
   <span class="font15">CSF </span>
   <span class="font15">acyclovir </span>
   <span class="font15">clinical </span>
   <span class="font15">size </span>
   <span class="font15">tau </span>
   <span class="font15">Institute </span>
   <span class="font15">dose </span>
   <span class="font15">levels </span>
   <span class="font15">mild </span>
   <span class="font14">MRI </span>
   <span class="font14">data </span>
   <span class="font14">measures </span>
   <span class="font14">Hypothesis </span>
   <span class="font14">disease </span>
   <span class="font14">viral </span>
   <span class="font14">AD. </span>
   <span class="font14">National </span>
   <span class="font14">impairment </span>
   <span class="font14">phase </span>
   <span class="font14">test </span>
   <span class="font14">type </span>
   <span class="font13">ADAS-Cog </span>
   <span class="font13">HSV, </span>
   <span class="font13">Patients </span>
   <span class="font13">cortical </span>
   <span class="font13">daily </span>
   <span class="font13">disease. </span>
   <span class="font13">infection </span>
   <span class="font13">placebo </span>
   <span class="font13">DNA </span>
   <span class="font13">Disease </span>
   <span class="font13">baseline </span>
   <span class="font13">effects </span>
   <span class="font13">including </span>
   <span class="font13">outcome </span>
   <span class="font13">serum </span>
   <span class="font13">temporal </span>
   <span class="font13">Data </span>
   <span class="font13">F-Florbetapir </span>
   <span class="font13">Valacyclovir </span>
   <span class="font13">consent </span>
   <span class="font13">double-blind, </span>
   <span class="font13">results </span>
   <span class="font13">treated </span>
   <span class="font13">trial. </span>
   <span class="font13">uptake </span>
   <span class="font12">AD, </span>
   <span class="font12">Department </span>
   <span class="font12">ROIs </span>
   <span class="font12">YorkNew </span>
   <span class="font12">YorkUSA[], </span>
   <span class="font12">analysis </span>
   <span class="font12">antibodies </span>
   <span class="font12">apoE </span>
   <span class="font12">criteria </span>
   <span class="font12">decline </span>
   <span class="font12">efficacy </span>
   <span class="font12">grant </span>
   <span class="font12">major </span>
   <span class="font12">multiple </span>
   <span class="font12">oral </span>
   <span class="font12">px; </span>
   <span class="font12">score </span>
   <span class="font12">sum </span>
   <span class="font12">used </span>
   <span class="font12">using </span>
   <span class="font12">{font-family </span>
   <span class="font12">Medical </span>
   <span class="font12">York </span>
   <span class="font12">blood </span>
   <span class="font12">changes </span>
   <span class="font12">evidence </span>
   <span class="font12">font-size </span>
   <span class="font12">memory </span>
   <span class="font12">randomised, </span>
   <span class="font12">safety </span>
   <span class="font12">scan </span>
   <span class="font12">seropositivity </span>
   <span class="font12">study. </span>
   <span class="font12">superior </span>
   <span class="font12">-week </span>
   <span class="font12">Centre </span>
   <span class="font12">Change </span>
   <span class="font12">Clinical </span>
   <span class="font12">III </span>
   <span class="font12">assessment </span>
   <span class="font12">based </span>
   <span class="font12">change </span>
   <span class="font12">deficits </span>
   <span class="font12">detectable </span>
   <span class="font12">disease: </span>
   <span class="font12">double; </span>
   <span class="font12">estimated </span>
   <span class="font12">exposure </span>
   <span class="font12">group </span>
   <span class="font12">increased </span>
   <span class="font12">individuals </span>
   <span class="font12">lead </span>
   <span class="font12">medial </span>
   <span class="font12">medications </span>
   <span class="font12">older </span>
   <span class="font12">positive </span>
   <span class="font12">prior </span>
   <span class="font12">reduce </span>
   <span class="font12">risk </span>
   <span class="font12">scans </span>
   <span class="font12">scores </span>
   <span class="font12">support </span>
   <span class="font12">trials </span>
   <span class="font12">use </span>
   <span class="font11">Aging </span>
   <span class="font11">Alzheimer </span>
   <span class="font11">Alzheimers </span>
   <span class="font11">Columbia </span>
   <span class="font11">New </span>
   <span class="font11">Pennsylvania </span>
   <span class="font11">State </span>
   <span class="font11">Treatment </span>
   <span class="font11">adults </span>
   <span class="font11">association </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cause </span>
   <span class="font11">cerebrospinal </span>
   <span class="font11">cognition </span>
   <span class="font11">compared </span>
   <span class="font11">conducted </span>
   <span class="font11">dementia </span>
   <span class="font11">diagnosis </span>
   <span class="font11">effects. </span>
   <span class="font11">emission </span>
   <span class="font11">examine </span>
   <span class="font11">exploratory </span>
   <span class="font11">imaging </span>
   <span class="font11">increase </span>
   <span class="font11">inferior </span>
   <span class="font11">measure </span>
   <span class="font11">neurological </span>
   <span class="font11">new </span>
   <span class="font11">patient </span>
   <span class="font11">placebo-controlled </span>
   <span class="font11">plaques </span>
   <span class="font11">positron </span>
   <span class="font11">primary </span>
   <span class="font11">protocol </span>
   <span class="font11">range </span>
   <span class="font11">research </span>
   <span class="font11">sample </span>
   <span class="font11">similar </span>
   <span class="font11">solid; </span>
   <span class="font11">tests </span>
   <span class="font11">time-points </span>
   <span class="font11">valacyclovir, </span>
   <span class="font11">viruses </span>
   <span class="font11">weeks, </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(Hypothesis </span>
   <span class="font11">ADCS-ADL </span>
   <span class="font11">Cognitive </span>
   <span class="font11">F-MK- </span>
   <span class="font11">HSV. </span>
   <span class="font11">IgG </span>
   <span class="font11">Mental </span>
   <span class="font11">Patient </span>
   <span class="font11">Psychiatric </span>
   <span class="font11">Research </span>
   <span class="font11">Safety </span>
   <span class="font11">Statistical </span>
   <span class="font11">UPSIT </span>
   <span class="font11">acute </span>
   <span class="font11">analyses </span>
   <span class="font11">antibody </span>
   <span class="font11">bold </span>
   <span class="font11">cingulate, </span>
   <span class="font11">common </span>
   <span class="font11">conduct </span>
   <span class="font11">consultant </span>
   <span class="font11">control </span>
   <span class="font11">courier; </span>
   <span class="font11">daily. </span>
   <span class="font11">dementia, </span>
   <span class="font11">dementia. </span>
   <span class="font11">drug </span>
   <span class="font11">duration </span>
   <span class="font11">em; </span>
   <span class="font11">evaluate </span>
   <span class="font11">fluid </span>
   <span class="font11">followed </span>
   <span class="font11">function </span>
   <span class="font11">genotype </span>
   <span class="font11">gyrus, </span>
   <span class="font11">include </span>
   <span class="font11">includes </span>
   <span class="font11">is, </span>
   <span class="font11">latent </span>
   <span class="font11">linear </span>
   <span class="font11">main </span>
   <span class="font11">months </span>
   <span class="font11">obtain </span>
   <span class="font11">obtained </span>
   <span class="font11">occur </span>
   <span class="font11">olfactory </span>
   <span class="font11">outcomes, </span>
   <span class="font11">placebo) </span>
   <span class="font11">placebo-controlled, </span>
   <span class="font11">placebo. </span>
   <span class="font11">power </span>
   <span class="font11">provide </span>
   <span class="font11">pt;} </span>
   <span class="font11">random </span>
   <span class="font11">randomisation </span>
   <span class="font11">relationship </span>
   <span class="font11">respectively. </span>
   <span class="font11">results. </span>
   <span class="font11">shown </span>
   <span class="font11">significance </span>
   <span class="font11">significant </span>
   <span class="font11">specific </span>
   <span class="font11">subject </span>
   <span class="font11">tested </span>
   <span class="font11">total </span>
   <span class="font11">weeks), </span>
   <span class="font11">years </span>
   <span class="font11">â€‰mg </span>
   <span class="font11">â€“â€‰g </span>
  </p>
 </body>
</html>
